Weight Loss Drugs

• Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks

  Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.

  Health

  Dec 3
  
• Trump says prices for Ozempic, other weight-loss drugs to drop in U.S.

  Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.

  U.S. News

  Nov 6
  
• Advertisement
• Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows

  A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

  Health

  Jun 3
• Advertisement
• Drugs like Ozempic may lower cancer risk if you have diabetes: study

  Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

  Health

  May 23
• The Ozempic debate: Large study reveals the good and the bad

  A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

  Health

  Jan 21
• Biden proposes coverage for weight-loss drugs for millions of obese Americans

  While the rule would give millions of people access to weekly injectables that have helped people shed pounds, it would cost taxpayers as much as $35 billion over the next decade.

  Health

  Nov 26, 2024
• Weight-loss medication helps mom manage her obesity. Quebec won’t pay for any of it

  Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.

  Canada

  Oct 24, 2024
• Wegovy now in Canada: Who should (and shouldn’t) use the weight-loss drug

  After years of persistent shortages, Canadians can now access Wegovy, an on-label weight loss medication, made by the same manufacturers of Ozempic.

  Health

  May 6, 2024
• Advertisement
• What is Zepbound? Could the weight-loss drug work better than Ozempic?

  Zepbound has been approved in the U.S. for weight loss, and studies show it could be the best-performing obesity drug to date.

  Health

  Nov 10, 2023
• Advertisement
• Eli Lilly’s new version of diabetes drug Mounjaro approved for weight loss by FDA

  A new version of the popular diabetes treatment Mounjaro from Eli Lilly can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

  Health

  Nov 8, 2023